Steris STE
NYSE STE
$215.02 -3.42 (-1.57%)
As of: Sep 9, 2026 · 3:59 PM EDT

Steris (STE) Cash from Investing Activities (2018 - 2026)

Steris (STE) posted Cash from Investing Activities of -$108.5 million for Q2 2026, up 50.05% on a QoQ basis from -$217.2 million in Q1 2026, and little changed year-over-year from -$108.5 million in Q2 2025.

Analysis

Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Steris has reported Cash from Investing Activities for 9 years, with the latest figure at -$108.5 million in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities changed 0.0% year-over-year to -$108.5 million in Q2 2026; TTM through Jun 2026 was -$512.5 million, a 25.77% decrease from a year earlier, with the FY2026 full-year figure at -$512.5 million, down 231.82% from the prior year.
  • Cash from Investing Activities was -$108.5 million for Q2 2026 at Steris, up from -$217.2 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $687.8 million in Q2 2024, with the low at -$606.2 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$78.3 million, with a median of -$98.5 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 519.08% in 2023, then surged 1132.79% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$98.4 million in 2022, then decreased by 20.84% to -$118.9 million in 2023, then declined by 4.19% to -$123.9 million in 2024, then climbed by 20.5% to -$98.5 million in 2025, then decreased by 10.15% to -$108.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$108.5 million (Q2 2026), -$217.2 million (Q1 2026), and -$98.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -190.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -108.50 Mn
Mar 31, 2026 -217.20 Mn
Dec 31, 2025 -98.50 Mn
Sep 30, 2025 -88.30 Mn
Jun 30, 2025 -108.50 Mn
Mar 31, 2025 -69.80 Mn
Dec 31, 2024 -123.90 Mn
Sep 30, 2024 -105.30 Mn
Jun 30, 2024 687.80 Mn
Mar 31, 2024 -95.65 Mn
Dec 31, 2023 -118.92 Mn
Sep 30, 2023 -606.24 Mn
Jun 30, 2023 -66.60 Mn
Mar 31, 2023 -77.58 Mn
Dec 31, 2022 -98.41 Mn
Sep 30, 2022 -97.93 Mn
Jun 30, 2022 -109.42 Mn
Mar 31, 2022 93.58 Mn
Dec 31, 2021 -79.80 Mn
Sep 30, 2021 -76.80 Mn